Dr Catherine Osborne, CEO
Catherine has been running Crux Biolabs since the start of 2017 and has 18+ years’ experience working with microbiology, molecular biology and immunology researchers.
Catherine developed a particular interest in microbiome analysis using next-generation sequencing as a Postdoctoral Research Fellow at University of California, Berkeley.
Her past academic appointments in Australia include University of Melbourne, CSIRO and Monash University and she’s had previous commercial roles at Thermo Fisher Scientific and Jomar Life Research.
When Catherine isn’t helping advance research, she likes to dance.